Amgen (AMGN) Tops Q1 EPS by 35c, Offers Guidance
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $439.33 +1.29%
Financial Fact:
Interest and other income, net: 216M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Interest and other income, net: 216M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q1 EPS of $5.15, $0.35 better than the analyst estimate of $4.80. Revenue for the quarter came in at $8.62 billion versus the consensus estimate of $8.59 billion.
GUIDANCE:
Amgen sees FY2026 EPS of $21.70-$23.10, versus the consensus of $22.30. Amgen sees FY2026 revenue of $37.1-38.5 billion, versus the consensus of $37.79 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FTC files amicus brief challenging Amgen's Enbrel patent acquisition
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Lazard Global Total Return fund declares $0.1534 monthly distribution
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
